AQR Arbitrage’s BioTelemetry, Inc. BEAT Stock Holding History

AQR Arbitrage’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-80,337	Closed	-$5.79M	–	1568
2020 Q4	$5.79M	Buy	+80,337	New	+$4.21M	0.2%	113

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

AQR Arbitrage's BEAT Position: Q1 2021 in Review

AQR Arbitrage sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 80,337 shares — an estimated $5.79M sold.

AQR Arbitrage first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $5.79M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

AQR Arbitrage reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 80,337 BioTelemetry, Inc. shares in Q1 2021, an estimated $5.79M.
AQR Arbitrage first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's BioTelemetry, Inc. position peaked at $5.79M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.